Mediplantex National Pharmaceutical JSC (MED) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

VND 312,732 Million (Micro Cap)

P/E

24.00

Industry P/E

Dividend Yield

4.76%

Debt Equity

0.03

Return on Equity

3.71%

Price to Book

0.96

Revenue and Profits:

Net Sales:

86,903 Million

(Quarterly Results - Jun 2025)

Net Profit:

3,042 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

10.53%

6 Months

-4.91%

1 Year

1.61%

2 Years

-3.08%

3 Years

9.57%

4 Years

-23.01%

5 Years

-15.7%

Mediplantex National Pharmaceutical JSC for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-8.98%

EBIT Growth (5y)

-9.91%

EBIT to Interest (avg)

3.00

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

0.02

Sales to Capital Employed (avg)

1.05

Tax Ratio

21.62%

Dividend Payout Ratio

98.12%

Pledged Shares

Institutional Holding

ROCE (avg)

7.88%

ROE (avg)

4.86%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.87

EV to EBIT

16.83

EV to EBITDA

12.72

EV to Capital Employed

0.88

EV to Sales

0.80

PEG Ratio

Dividend Yield

5.31%

ROCE (Latest)

5.21%

ROE (Latest)

3.62%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 15.21% vs -28.79% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 39.51% vs -24.90% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "86,903.00",
          "val2": "75,429.80",
          "chgp": "15.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6,268.90",
          "val2": "4,833.50",
          "chgp": "29.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "699.60",
          "val2": "411.10",
          "chgp": "70.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,041.60",
          "val2": "2,180.20",
          "chgp": "39.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.50%",
          "val2": "40.20%",
          "chgp": "0.93%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.03% vs 0.42% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 29.28% vs 95.02% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "443,135.80",
          "val2": "402,741.20",
          "chgp": "10.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29,874.70",
          "val2": "22,624.80",
          "chgp": "32.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2,417.30",
          "val2": "5,394.40",
          "chgp": "-55.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15,182.60",
          "val2": "11,743.90",
          "chgp": "29.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.90%",
          "val2": "35.20%",
          "chgp": "1.47%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

86,903.00

75,429.80

15.21%

Operating Profit (PBDIT) excl Other Income

6,268.90

4,833.50

29.70%

Interest

699.60

411.10

70.18%

Exceptional Items

0.00

Consolidate Net Profit

3,041.60

2,180.20

39.51%

Operating Profit Margin (Excl OI)

49.50%

40.20%

0.93%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 15.21% vs -28.79% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 39.51% vs -24.90% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

443,135.80

402,741.20

10.03%

Operating Profit (PBDIT) excl Other Income

29,874.70

22,624.80

32.04%

Interest

2,417.30

5,394.40

-55.19%

Exceptional Items

0.00

Consolidate Net Profit

15,182.60

11,743.90

29.28%

Operating Profit Margin (Excl OI)

49.90%

35.20%

1.47%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 10.03% vs 0.42% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 29.28% vs 95.02% in Dec 2023

All Annual Results

Company CV

About Mediplantex National Pharmaceutical JSC

Mediplantex National Pharmaceutical JSC

Pharmaceuticals & Biotechnology

Mediplantex National Pharmaceutical Joint Stock Company is a Vietnam-based company active in the pharmaceutical industry. The Company is engaged in the manufacturing of pharmaceutical products, including various types of pharmaceutical preparations and medicinal and botanical preparations, as well as herb farming. Besides, it is involved in the import, export and wholesale and retail trading of pharmaceutical products through its drug stores. The Company is also investing in real estate projects so as to lease offices, apartments and warehouse.

Company Coordinates

Company Details

358 Giai Phong , HANOI None : None

Tel: 84 4 38643360

http://www.mediplantex.com/

Registrar Details